Stakeholder Analysis

Objectives

Practice stakeholder analysis method. This exercise provides a general framework for analyzing stakeholders and their incentives. The specific reactions and interests of stakeholders may vary based on the cultural, social, and political context in which the debate takes place.

Participants

Suitable both for solo learners and groups

Task

The exercise presents a worksheet with useful questions to guide you when using the stakeholder approach. Read the motion listed below and answer questions.

***

Who are the stakeholders associated with the motion, "This House would legalize all recreational drugs"?

(See Answer 1)


***
How are the agents and actors connected to the motion, and what are their incentives?

(See Answer 2)



***
How do you predict each stakeholder will react to the motion?

(See Answer 3)

Answer 1
  • Individuals - General public, drug users, parents, healthcare professionals, law enforcement officers, drug dealers.
  • Groups - Drug policy reform organizations, addiction treatment centers, pharmaceutical companies.
  • Social Movements - Anti-drug organizations, harm reduction movements, grassroots advocacy groups.
  • Corporations - Pharmaceutical companies, private prison companies, drug testing laboratories.
  • Governments - Local, state, and federal authorities responsible for drug enforcement and legislation.
  • Institutions - Schools, universities, hospitals, law enforcement agencies.
Answer 2
  • Individuals - Drug users may have a personal incentive to support drug legalization, while parents may be concerned about potential harms. Healthcare professionals may have varying opinions based on their experiences. Law enforcement officers may have concerns about increased drug-related crimes or workload. Drug dealers may have an incentive to support legalization to remove legal barriers.
  • Groups - Drug policy reform organizations have an incentive to advocate for a change in drug legislation. Addiction treatment centers may have concerns about potential impacts on substance abuse rates and their services. Pharmaceutical companies may see opportunities for research and development of legalized drugs. Civil liberties organizations may advocate for individual freedom and reduced criminalization.
  • Social Movements - Anti-drug organizations may strongly oppose the motion due to concerns about public health and safety. Harm reduction movements may support the motion to reduce drug81 related harms and promote safer drug use. Grassroots advocacy groups may align with different perspectives depending on their values and priorities.
  • Corporations - Pharmaceutical companies may be interested in potential market opportunities and the development of legalized drugs. Private prison companies may have concerns about potential impacts on their business if drug-related offenses decrease. Drug testing laboratories may see changes in demand for their services.
  • Governments - Local, state, and federal authorities may have varying perspectives on drug legalization, considering factors like public opinion, public health concerns, crime rates, and international drug control agreements. Their incentives may include promoting public safety, addressing addiction, and balancing individual liberties with societal well-being.
  • Institutions - Schools, universities, hospitals, and law enforcement agencies may have specific policies and protocols related to drug use and enforcement. They may be concerned about the potential impact of drug legalization on their operations and duty of care.
Answer 3
  • Individuals - Responses will vary. Drug users may support legalization for personal reasons, while concerned parents may oppose it. Healthcare professionals may have a range of opinions based on their expertise and experiences. Law enforcement officers may express concerns about potential negative consequences. Drug dealers may generally support legalization to remove legal barriers to their activities.
  • Groups - Drug policy reform organizations are likely to support the motion. Addiction treatment centers may have concerns about increased substance abuse rates. Pharmaceutical companies may see potential business opportunities. Civil liberties organizations may support the motion based on principles of individual freedom.
  • Social Movements - Anti-drug organizations will likely strongly oppose the motion. Harm reduction movements may support it to minimize harm and promote safety. Grassroots advocacy groups may align with different perspectives depending on their values and priorities.
  • Corporations - Pharmaceutical companies may support the motion for potential market expansion. Private prison companies may oppose it due to potential impacts on their business. Drug testing laboratories may see changes in demand for their services.
  • Governments - Responses will vary depending on political, social, and economic factors. Some authorities may oppose the motion due to concerns about public health and safety, while others may support it based on principles of personal freedom or potential benefits.
  • Institutions - Schools, universities, hospitals, and law enforcement agencies may have internal policies and protocols that influence their stance on drug legalization. Their responses may be guided by the duty of care.